What does Dr. Veerle Van de Steene do?

Dr. Veerle Van de Steene is a specialist medical practice in Deinze. Private Limited, started on 27 August 2004, 1 establishment.

What is the address of Dr. Veerle Van de Steene?

The registered office of Dr. Veerle Van de Steene is located at Marie Stevensstraat 6, 9800 Deinze.

Is Dr. Veerle Van de Steene still active?

Yes. According to the CBE (15 November 2026) Dr. Veerle Van de Steene is active, legal situation “Normale toestand”, started on 27 August 2004.

Is Dr. Veerle Van de Steene registered on Peppol?

Yes, Dr. Veerle Van de Steene is registered on the Peppol network with ID 0208:0867144168.

What is the enterprise number of Dr. Veerle Van de Steene?

The enterprise number of Dr. Veerle Van de Steene is BE0867144168.

When was Dr. Veerle Van de Steene founded?

Dr. Veerle Van de Steene was founded on 27 August 2004.

Who are the directors of Dr. Veerle Van de Steene?

According to the 2025 annual accounts, the directors of Dr. Veerle Van de Steene are: Veerle Van de Steene.

Is Dr. Veerle Van de Steene a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 August 2004; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Veerle Van de Steene make in 2025?

Dr. Veerle Van de Steene posted a profit after taxes of € 49,704 in financial year 2025.

What is the revenue of Dr. Veerle Van de Steene?

As a small company, Dr. Veerle Van de Steene is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 94,542.

Dr. Veerle Van de Steene (Private Limited) - Deinze

Dossier Dr. Veerle Van de Steene, printed on 15 November 2026 from databakkes.be/en/0867144168/dr-veerle-van-de-steene. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Veerle Van de Steene from Deinze, company number BE0867144168, closed financial year 2025 with a result of € 49,704 after tax. For that financial year Dr. Veerle Van de Steene recorded a gross margin of € 94,542 and equity of € 326,738. Compared with financial year 2024, the result moved from € 81,538 to € 49,704. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 30, 2026.

What it is worth Growing

€ 326,738

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 49,704

▼ 39% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 38,309

▼ 21% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 47,971 paid out

97 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 15,241

▲ 9% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 6,736

▲ 71% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 5,569

▲ 43% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 4,556

▼ 79% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 86,016 Gross margin 2022: € 86,016 First fiscal year in the series	€ 76,172 Gross margin 2023: € 76,172 ▼ 11% vs 2022 (€ 86,016) Unfavourable step	€ 148,418 Gross margin 2024: € 148,418 ▲ 95% vs 2023 (€ 76,172) Favourable step	€ 94,542 Gross margin 2025: € 94,542 ▼ 36% vs 2024 (€ 148,418) Unfavourable step	▼ 36%
Profit after taxes	€ 46,770 Profit after taxes 2022: € 46,770 First fiscal year in the series	€ 36,313 Profit after taxes 2023: € 36,313 ▼ 22% vs 2022 (€ 46,770) Unfavourable step	€ 81,538 Profit after taxes 2024: € 81,538 ▲ 125% vs 2023 (€ 36,313) Favourable step	€ 49,704 Profit after taxes 2025: € 49,704 ▼ 39% vs 2024 (€ 81,538) Unfavourable step	▼ 39%
Equity	€ 251,105 Equity 2022: € 251,105 First fiscal year in the series	€ 267,763 Equity 2023: € 267,763 ▲ 7% vs 2022 (€ 251,105) Favourable step	€ 325,005 Equity 2024: € 325,005 ▲ 21% vs 2023 (€ 267,763) Favourable step	€ 326,738 Equity 2025: € 326,738 ▲ 1% vs 2024 (€ 325,005) Favourable step	▲ 1%
Total debts	€ 11,944 Total debts 2022: € 11,944 First fiscal year in the series	€ 11,542 Total debts 2023: € 11,542 ▼ 3% vs 2022 (€ 11,944) Favourable step	€ 25,544 Total debts 2024: € 25,544 ▲ 121% vs 2023 (€ 11,542) Unfavourable step	€ 60,125 Total debts 2025: € 60,125 ▲ 135% vs 2024 (€ 25,544) Unfavourable step	▲ 135%
Cash	€ 46,612 Cash 2022: € 46,612 First fiscal year in the series	€ 35,692 Cash 2023: € 35,692 ▼ 23% vs 2022 (€ 46,612) Unfavourable step	€ 48,533 Cash 2024: € 48,533 ▲ 36% vs 2023 (€ 35,692) Favourable step	€ 38,309 Cash 2025: € 38,309 ▼ 21% vs 2024 (€ 48,533) Unfavourable step	▼ 21%
Retained profit	€ 238,705 Retained profit 2022: € 238,705 First fiscal year in the series	€ 249,163 Retained profit 2023: € 249,163 ▲ 4% vs 2022 (€ 238,705) Favourable step	€ 306,405 Retained profit 2024: € 306,405 ▲ 23% vs 2023 (€ 249,163) Favourable step	€ 308,138 Retained profit 2025: € 308,138 ▲ 1% vs 2024 (€ 306,405) Favourable step	▲ 1%
Dividend	€ 69,660 Dividend 2022: € 69,660 First fiscal year in the series	€ 25,855 Dividend 2023: € 25,855 ▼ 63% vs 2022 (€ 69,660) Unchanged	€ 24,296 Dividend 2024: € 24,296 ▼ 6% vs 2023 (€ 25,855) Unchanged	€ 47,971 Dividend 2025: € 47,971 ▲ 97% vs 2024 (€ 24,296) Unchanged	▲ 97%
Bank debt	€ 4,118 Bank debt 2022: € 4,118 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 4,118) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 263,049 Balance sheet total 2022: € 263,049 First fiscal year in the series	€ 279,304 Balance sheet total 2023: € 279,304 ▲ 6% vs 2022 (€ 263,049) Unchanged	€ 350,549 Balance sheet total 2024: € 350,549 ▲ 26% vs 2023 (€ 279,304) Unchanged	€ 386,863 Balance sheet total 2025: € 386,863 ▲ 10% vs 2024 (€ 350,549) Unchanged	▲ 10%

By gross margin, Dr. Veerle Van de Steene ranks 31st of 34 companies with main activity “Activiteiten van medisch specialisten” in Deinze that publish figures (fiscal year 2025).

Key figures of Dr. Veerle Van de Steene, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

Ask about Dr. Veerle Van de Steene the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to Dr. Veerle Van de Steene?

What happened at Dr. Veerle Van de Steene in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 30, 2026 New annual accounts for financial year 2025: profit of € 49,704 (▼ 39% vs 2024). Source: NBB ↗
2004 Veerle Van de Steene became a director. NBB
Aug 27, 2004 New establishment in Deinze. KBO
Aug 27, 2004 Start of the company according to the CBE. KBO

In short

From € 46,770 profit in 2022 to € 49,704 profit in 2025.

Paid € 96,262 in corporate taxes since 2022.

Best year ever: 2024, with € 81,538 profit.

Paid out € 167,782 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Veerle Van de Steene

Dr. Veerle Van de Steene

Behind Dr. Veerle Van de Steene is Veerle Van de Steene.

Directors

According to the 2025 annual accounts

Veerle Van de Steene

Director

since 2004

Establishments

Establishment units

Physical locations of this company

Registered office

Marie Stevensstraat 6

9800 Deinze

2.224.417.262

Schutterijstraat 34

9800 Deinze

Active since 27 August 2004

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Viabarcas

€ 139,382 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Deinze

Same main activity (Activiteiten van medisch specialisten), 35 active companies in Deinze, largest first.

DR. PIETER BYN

€ 1.1 million gross margin · 2025

Dr. Christian Decock, oftalmoloog

€ 905,279 gross margin · 2025

Dr. Radioloog Maxim Behaeghe

€ 787,207 gross margin · 2025

PGS

€ 672,422 gross margin · 2025

DR. THOMAS DECLERCK

€ 514,950 gross margin · 2025

Dr. P. Zenner Cardiologie

€ 484,191 gross margin · 2025

All companies with this activity → Largest companies in Deinze →

Details

Company number: 0867.144.168
VAT number: BE 0867.144.168
Registered office: Marie Stevensstraat 6, 9800 Deinze
Names & denominations: Dr. Veerle Van de Steene
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 August 2004
Peppol: Active · Active since 28 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗